Our Science
We are targeting new pathways to fight cancer at its core tumorigenic mechanisms. We combine our deep scientific foundation in molecular cancer biology, tumorigenesis, and cancer stem cell biology, with expertise in preclinical and clinical drug development to advance novel therapeutics to treat advanced cancers.
Follow the Science
Our Targets
Our targets represent previously unexplored mechanisms of tumorigenesis.
Our first target is KDM4, an epigenetic
regulator that controls gene expression, cell proliferation, stem cell maintenance, apoptosis, and metastasis.
Innovators in Our Field
Tachyon operates with a dedicated internal core development team and a broad virtual external network of expertise to achieve one goal – advance our programs with speed and innovation, without compromising the quality or integrity of our science.